These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3636332)

  • 41. Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin).
    Manek N; Wise R; Donovan IA
    J Antimicrob Chemother; 1987 Mar; 19(3):363-6. PubMed ID: 3494723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
    File TM; Tan JS; Salstrom SJ; Johnson LA; Douglas GF
    Antimicrob Agents Chemother; 1984 Sep; 26(3):310-3. PubMed ID: 6508263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Timentin (ticarcillin and clavulanic acid) in combination with aminoglycosides in the treatment of febrile episodes in neutropenic children.
    Schaison G; Reinert P; Leverger G; Leauté JB
    J Antimicrob Chemother; 1986 May; 17 Suppl C():177-81. PubMed ID: 3722043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH; Eggleston M
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timentin therapy for bone, joint, and deep soft tissue infections in children.
    Jacobs RF; Augustine RA; Aronson J; McCarthy RE; Steele RW; Yamauchi T
    Am J Med; 1985 Nov; 79(5B):188-91. PubMed ID: 4073090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timentin--ticarcillin plus clavulanic acid. A laboratory and clinical perspective. Based on an international symposium. Monte Carlo, 3-4 December 1985.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-244. PubMed ID: 3722041
    [No Abstract]   [Full Text] [Related]  

  • 48. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint.
    Johnson CC; Reinhardt JF; Wallace SL; Terpenning MS; Helsel CL; Mulligan ME; Finegold SM; George WL
    Am J Med; 1985 Nov; 79(5B):136-40. PubMed ID: 4073081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.
    Jungbluth GL; Cooper DL; Doyle GD; Chudzik GM; Jusko WJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):896-900. PubMed ID: 3492959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Timentin versus moxalactam in the treatment of skin and soft tissue infections.
    Tan JS; File TM; Salstrom SJ
    Am J Med; 1985 Nov; 79(5B):130-3. PubMed ID: 4073079
    [No Abstract]   [Full Text] [Related]  

  • 53. An evaluation of the safety and tolerance of Timentin.
    Croydon EA; Hermoso C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():233-40. PubMed ID: 3722045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ticarcillin/clavulanate in the treatment of pelvic infections.
    Lucas MJ; Cox SM; Roark ML; Cunningham FG
    J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
    Höffken G; Tetzel H; Koeppe P; Lode H
    J Antimicrob Chemother; 1986 May; 17 Suppl C():47-55. PubMed ID: 3722046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of ticarcillin plus clavulanic acid with clindamycin and gentamicin in the treatment of postcesarean endomyometritis.
    Apuzzio JJ; Ganesh V; Kaminski Z; Bergen B; Holland B; Louria DB
    Surg Gynecol Obstet; 1988 May; 166(5):413-7. PubMed ID: 3259017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
    Pankey GA; Katner HP; Valainis GT; Clarkson MJ; Cortez LM; Dalovisio JR
    Am J Med; 1985 Nov; 79(5B):106-15. PubMed ID: 4073076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections.
    File TM; Tan JS
    Rev Infect Dis; 1991; 13 Suppl 9():S733-6. PubMed ID: 1925317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.